our plans regarding presentations of the results of preclinical data, the DNase platform improving outcomes of existing ...

The assembly featured remarks from Dr. Headrick, who spoke passionately about the importance of early detection and community ...

Researchers at the University of Navarra’s DATAI Institute (Spain) have created an AI-powered tool called the “IFIT score” to ...

In November, Mural presented clinical and preclinical data at the 39 th Annual Meeting of the Society for Immunotherapy of ...

Positive Phase 2 End of Study Data with Bel-sar in Early-Stage Choroidal Melanoma; Ongoing Phase 3 CoMpass Trial Recently Received Authorization to Start Enrolling Patients in Europe Multiple Clinical ...

Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, ...

Five BriaCell poster presentations to highlight updated survival and key biomarker data from Phase 2 trial of Bria-IMT™ plus immune check point ...

TEXILA American University held its Pinktober event on October 25, 2024, at its Providence, East Bank Demerara location which ...

Good morning and welcome to Agenus' third quarter 2024 conference call and webcast. All participants will be in a listen-only ...

“When we analyzed the mitochondrial morphology of different breast cancer cell lines, we observed that those ...

Olema Pharmaceuticals, Inc. (“Olema”, “”, Nasdaq: OLMA), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for breast cancer ...

Five BriaCell poster presentations to highlight updated survival and key biomarker data from Phase 2 trial of Bria-IMT™ plus immune check point inhibitor in metastatic breast cancer ...